The threat from diseases is becoming more frightening, but the good thing is, several companies from around the world are doing the best that they can to fight off these diseases. They have been developing new treatments, and they are innovating the ones that have been existing for years to be more effective. Paragon Biosciences led by Jeff Aronin is one of these companies which are developing new treatments for diseases that are too challenging to cure. The company also has a huge database of information surrounding traditional medicine, herbal medicine and other forms of alternative and what its effects to the people are, and they are trying to change it to fit the lifestyle of the 21st century. Paragon Biosciences is also known for being a multinational company that is providing a lot of investment options for their clients, especially for those who wanted to put money to invest in biopharmaceutical products.
Behind the success of the company is a true leader, in the persona of Jeff Aronin. He is one of the original co-founders of the company, but Jeff Aronin was just elected to become the chairman and CEO of Paragon Biosciences in 2010. The board of directors stated that they wanted to put their trust in someone who knows the company well and who understands what it truly needs. Aside from being the overall chairman and CEO of Paragon Biosciences, Jeff Aronin was also given minor roles by the board of directors, serving as the chairman for a number of their subsidiaries.
Jeff Aronin has a lot of work experience in the field of medicine and healthcare. Between the years 2000 to 2009, he was appointed to the position of the CEO and president of Ovation Pharmaceuticals, another company that he co-founded. He did a great job in making the company profitable, and because of his actions, many companies soon started knocking on his door offering him a lot of business contracts (https://angel.co/jeff-aronin). There were contracts for mergers, acquisitions, and partnerships, but what Jeff Aronin chose was to be acquired by Ovation Pharmaceuticals, because he was promised that his position within the company will be kept, meaning that he will still be the president and the CEO.